CHEK2 and cancer: Furthermore, germline pathogenic/likely pathogenic (P/LP) variants in cancer predisposition genes have shown a dose effect, resulting in a more severe phenotype in homozygous than heterozygous cases and for CHEK2 P/LP variants, the homozygous state confers a higher risk of BC than the heterozygous state [14,15].